Related Experiment Video

Updated: Oct 23, 2026

Implantation of Total Artificial Heart in Congenital Heart Disease
07:27

Implantation of Total Artificial Heart in Congenital Heart Disease

Published on: July 17, 2014

[Pacemaker implantation for heart failure with bradycardia (author's transl)]

A Dolder, J Halter, F Nager

    Deutsche Medizinische Wochenschrift (1946)
    |October 10, 1975
    PubMed

    Insights

    Pacemakers improve survival and heart function in bradycardic heart failure patients. However, long-term outcomes are less favorable for those with severe heart failure.

    Area of Science:

    • Cardiology
    • Medical Devices
    • Clinical Research

    Context:

    • Bradycardic heart failure presents significant management challenges.
    • Syncope and heart failure impact patient prognosis.
    • Pacemaker implantation is a key intervention for bradycardia.

    Purpose:

    • To evaluate the long-term efficacy of pacemakers in patients with bradycardic heart failure, with or without syncope.
    • To assess survival rates and functional status post-pacemaker implantation across different patient groups.

    Summary:

    • This study analyzed 337 patients undergoing pacemaker implantation for bradycardic heart failure.
    • Survival rates varied significantly by group: Adams-Stokes attacks without heart failure (Group I), with heart failure (Group II), and heart failure alone (Group III).
    • Group II patients (mild/moderate heart failure) showed definite improvement, while Group III (severe heart failure) had mixed results.

    Impact:

    • Pacemakers offer improved survival and functional capacity for many bradycardic heart failure patients.
    • Long-term prognosis remains guarded for individuals with severe heart failure and bradycardia, even with pacemakers.
    • Findings inform clinical decision-making regarding pacemaker use in complex cardiac conditions.

    More Related Videos

    Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine10:08

    Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine

    Published on: February 17, 2018

    Translational Rabbit Model of Chronic Cardiac Pacing06:14

    Translational Rabbit Model of Chronic Cardiac Pacing

    Published on: January 6, 2023

    Related Concept Videos

    Decreased pulse rate01:14

    Decreased pulse rate

    Bradycardia is a medical condition in which the heart rate is slower than normal. It occurs when the heart's natural pacemaker, the sinus node, generates slower electrical impulses than the standard rhythm. In adults, bradycardia is diagnosed when the pulse rate falls below 60 beats per minute, indicating a deviation from the normal heart rate range.
    There are specific risk factors that can elevate the likelihood of developing bradycardia. Advanced age is a significant factor, with bradycardia...
    Dysrhythmias II: Classification of Tachyarrhythmias01:28

    Dysrhythmias II: Classification of Tachyarrhythmias

    Tachyarrhythmias are a type of dysrhythmia where the heart rate exceeds 100 beats per minute. Here are some common types of tachyarrhythmias:Sinus TachycardiaSinus tachycardia originates from increased impulses from the sinus node, leading to an elevated heart rate. It is often triggered by stress, fever, or exercise.Patients may experience palpitations, a sensation of a racing heart, dizziness, and chest discomfort.Causes and Risk Factors: Common causes include physical exertion, emotional...
    Dysrhythmias IV: Characteristics of Bradyarrhythmias01:18

    Dysrhythmias IV: Characteristics of Bradyarrhythmias

    Bradyarrhythmias are cardiac rhythm disorders characterized by a slower-than-normal heart rate, typically defined as fewer than 60 beats per minute. Some of which are discussed here:Sinus BradycardiaSinus bradycardia presents a heart rate lower than 60 beats per minute, with a regular rhythm originating from the SA node. The ECG typically shows normal P waves preceding each QRS complex, a normal PR interval (0.12 to 0.20 seconds), and a normal QRS duration (0.06 to 0.10 seconds).First-Degree AV...
    Dysrhythmias VI: Management of Dysrhythmias01:25

    Dysrhythmias VI: Management of Dysrhythmias

    Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
    Cardiomyopathy II: Dilated Cardiomyopathy01:30

    Cardiomyopathy II: Dilated Cardiomyopathy

    Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
    Cardiomyopathy V: Interprofessional Care01:29

    Cardiomyopathy V: Interprofessional Care

    Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...